Therapeutic potential of targeting MASTL in lung adenocarcinoma

Key Points

• Targeting MASTL shows promise for improving outcomes in lung adenocarcinoma treatment.
• The expression of MASTL was significantly correlated with tumor progression and patient survival rates, indicating a potential biomarker.
• Analysis using tumor samples determined the MASTL role in the molecular pathways of lung adenocarcinoma.
• This study highlights the need for further clinical trials to validate findings in human subjects.